News Releases
Health Care & Hospitals
Most Read
- 23 May, 2013, 16:06 BST Extremism Has No Place in Great Britain
- 21 May, 2013, 14:02 BST One Direction 2014 Tour Announcement Trumps David Beckham Retirement News
- 21 May, 2013, 11:33 BST Judgment in Interflora Versus Marks and Spencer
Most Emailed
- 03 May, 2013, 15:27 BST PokerStars Named Best Mobile Poker Operator
- 09 May, 2013, 15:22 BST Flagship Food Group Agrees To Acquire UK Based Atlantic Foods Group
- 20 May, 2013, 09:00 BST Integreon Signs Three Year Library Services Agreement with Kennedys
Organisations in the News
The organisations with the most activity in PR Newswire's News Room
Frost & Sullivan Volcano Corporation Atradius N.V.Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customised feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Meet the Media events
Our events put key media contacts in front of PR&Comms professionals for educational purposes and relationship building. Hosted in London and across Europe.
- < Prev
1
- Next >
-
00:45 BST
Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2
- Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 durante las sesiones de ensayo... -
00:34 BST
Volcano annonce les résultats préliminaires de l'Étude ADVISE II et son intégration à l'essai SYNTAX2 lors des dernières sessions d'essai clinique en ligne à l'EuroPCR 2013.
-- Une étude prévisionnelle, multicentrique et en double aveugle confirme les résultats précédents de l'évaluation de... -
23 May, 2013, 18:21 BST
Die bei der EuroPCR präsentierten, neuen Daten zeigen, dass TriGuard das Volumen von Hirnverletzungen während TAVR-Operationen reduziert
- Die präsentierten neue klinische Daten von der DEFLECT-I-Studie zeigen, dass das Gerät TriGuard™ Cerebral Protection... -
23 May, 2013, 16:02 BST
De nouvelles données cliniques présentées à l'EuroPCR indiquent que TriGuard réduit le volume de lésions cérébrales lors d'une TAVI
- De nouvelles données cliniques provenant de l'étude DEFLECT-I indiquent que le dispositif de protection cérébrale... -
23 May, 2013, 15:26 BST
Press Statement on Behalf of the Singh Family (The Former Shareholders and Founders of Ranbaxy)
On 22 May 2013, Daiichi Sankyo released a press statement where, among other things, it was stated that it "believes that certain former... -
23 May, 2013, 14:01 BST
Study Finds 35 to 42 Percent Daily Cost Savings for Hospitals Using Flexi-Seal® Faecal Management System
-- Fewer Pressure Ulcers and Better Use of Nursing Time Also Cited A new study of the costs of managing faecal incontinence in intensive... -
23 May, 2013, 12:59 BST
LifeScan Announces Voluntary Recall for Certain OneTouch® Verio® Blood Glucose Meters
At extremely high glucose levels (1024 mg/dl and above), the meters will not operate as intended, which could potentially delay the diagnosis and... -
23 May, 2013, 11:23 BST
Cycle Stuff Direct Looks at Cycle Fitness Nutrition
Everyone knows that cycling is fantastic for our overall fitness and health, but what about nutrition and how it has an impact on cycle training?... -
23 May, 2013, 10:25 BST
Ranbaxy anuncia unos estándares empresariales mejorados e iniciativas de garantía de calidad
Ranbaxy Laboratories Limited (de aquí en adelante, Ranbaxy), una filial de Daiichi Sankyo Co., Ltd. (de aquí en adelante, Daiichi... -
23 May, 2013, 09:55 BST
Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013
-- Prospective, Multi-Center, Double-Blinded Study Confirms Prior Results in evaluating Volcano's iFR® (Instant Wave-Free Ratio™)... -
23 May, 2013, 09:09 BST
Ranbaxy annonce une amélioration des normes commerciales et des initiatives d'assurance de la qualité
Ranbaxy Laboratories Limited (ci-après, Ranbaxy), une filiale de Daiichi Sankyo Co., Ltd. (ci-après, Daiichi Sankyo), a annoncé le... -
23 May, 2013, 09:07 BST
American Society of Anesthesiologists Discontinues Paper Posters at 2013 Annual Meeting - All Posters Will Be Submitted, Displayed, and Published Using the ePostersLive Suite of Products
Following the successful partial transition to electronic posters at their 2012 annual meeting, the American Society of Anesthesiologists has... -
23 May, 2013, 09:02 BST
Los nuevos datos de EuroPCR demuestran que TriGuard reduce la lesión cerebral durante la TAVR
- Los nuevos datos clínicos presentados en EuroPCR demuestran que TriGuard reduce el volumen de lesión cerebral durante la TAVR... -
23 May, 2013, 08:44 BST
Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an
Ranbaxy Laboratories Limited (im Weiteren Ranbaxy), eine Tochtergesellschaft von Daiichi Sankyo Co., Ltd. (im Weiteren Daiichi Sankyo), gab am 22.... -
23 May, 2013, 08:00 BST
Astellas Receives Marketing Authorisation for VESOMNI™ From the Netherlands Medicines Evaluation Board
Netherlands first to approve new fixed-dose combination treatment for men with lower urinary tract symptoms associated with BPH ASTELLAS PHARMA... -
23 May, 2013, 08:00 BST
Astellas erhält von der niederländischen Arzneimittelbehörde die Marktzulassung für VESOMNI™
Die Niederlande sind das erste Land, in dem die neue Festdosis-Kombinationsbehandlung für Männer mit Symptomen der unteren Harnwege in... -
23 May, 2013, 08:00 BST
Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen
Nederland keurt als eerste nieuwe vaste-dosis combinatiebehandeling goed voor mannen met lagere urinewegsymptomen geassocieerd met BPH Astellas... -
22 May, 2013, 18:44 BST
New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR
- New clinical data presented from the DEFLECT-I study demonstrates that Keystone Heart's TriGuard™ Cerebral Protection... -
22 May, 2013, 17:24 BST
New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System
- Interim Data from REDUCE-HTN Clinical Program Presented Today at EuroPCR Boston Scientific Corporation (NYSE: BSX) today reported... -
22 May, 2013, 15:58 BST
Kepner-Tregoe, Inc. asciende a Chris Geraghty a consejero delegado
- El anterior director de Operaciones sustituye a Ray Baxter; se centrará en visión y crecimiento Kepner-Tregoe (KT), la...
- < Prev
1
- Next >
